2,4,6-Tribromo-3,5-difluoropyridine

Catalog No.: 
ACTRUT629
CAS No.: 
30841-93-1
Molecular Formula: 
C5Br3F2N
Molecular Weight: 
351.77
2,4,6-Tribromo-3,5-difluoropyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$84.00InquiryInquiry
250mg98%$121.00InquiryInquiry
1g98%$242.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,4,6-Tribromo-3,5-difluoropyridine
IUPAC Name2,4,6-tribromo-3,5-difluoropyridine
MDL No.MFCD03093767
Molecular FormulaC5Br3F2N
Molecular Weight351.77
SMILESFC1=C(Br)N=C(Br)C(F)=C1Br
InChI KeyGKWOSYZICRXPCI-UHFFFAOYSA-N
SynonymPyridine, 2,4,6-tribromo-3,5-difluoro-;3,5-DIFLUORO-2,4,6-TRIBROMOPYRIDINE;2,4,6-TRIBROMO-3,5-DIFLUOROPYRIDINE;2,4,6-TRIBROMO-3,5-DIFLUOROPYRIDINE 97%;2,4,6-Tribromodifluoro-pyridine
CAS No.30841-93-1

Safety Data

Pictogram
ToxicHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H301-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACTRUT629 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJSDN037 route compound structure diagram
    ACJSDN0377789-46-0In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTRUT629 route product structure diagram
    ACTRUT62930841-93-1
Inquiry

2. ACTRUT629 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAWBD401 route compound structure diagram
    ACAWBD4017774-34-7In Stock
  4. Then
  5. ACTRUT629 route product structure diagram
    ACTRUT62930841-93-1
Inquiry

3. ACTRUT629 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTRUT629 route product structure diagram
    ACTRUT62930841-93-1
Inquiry

Comments (0)